Prophylaxis

  • George W. Comstock
  • Lawrence J. Geiter
Chapter

Abstract

Two prophylactic measures are available in the control of tuberculosis and each has its place, depending on the epidemiologic situation. Immunization, or BCG vaccination, must be considered for the uninfected when there is a high risk of becoming infected. Preventive therapy, or chemoprophylaxis, is directed at those already infected, especially in situations in which the risk of infection is slight or where the risk of disease, given infection, is high.

Keywords

Preventive Therapy American Thoracic Society Mycobacterium Bovis Tuberculin Test United States Public Health 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.
This is a preview of subscription content, log in to check access.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Hart PD’A, Sutherland I: BCG and vole bacillus vaccines in the prevention of tuberculosis in adolescence and early adult life. Final report to the Medical Research Council. Br Med J 1977;2:293–295.PubMedCrossRefGoogle Scholar
  2. 2.
    Comstock GW, Livesay VT, Woolpert SF: Evaluation of BCG vaccination among Puerto Rican children. Am J Public Health 1974;64:283–291.PubMedCrossRefGoogle Scholar
  3. 3.
    Comstock GW, Woolpert SF, Livesay VT: Tuberculosis studies in Muscogee County, Georgia. Twenty-year evaluation of a community trial of BCG vaccination. Public Health Rep 1976;91:276–280.PubMedGoogle Scholar
  4. 4.
    Tripathy SP: Fifteen-year follow-up of the Indian BCG prevention trial. Bull Int Union Tuberc 1987;62:69–72.Google Scholar
  5. 5.
    International Union against Tuberculosis: Phenotypes of BCG-vaccines seed lot strains: Results of an international cooperative study. Tubercle 1978;59:139–142.CrossRefGoogle Scholar
  6. 6.
    Comstock GW: Identification of an effective vaccine against tuberculosis. Am Rev Respir Dis 1988;138:479–480.PubMedGoogle Scholar
  7. 7.
    Wiegeshaus EH, Harding G, McMurray D, et al: A cooperative evaluation of test systems used to assay tuberculosis vaccines. Bull WHO 1971;45:543–550.PubMedGoogle Scholar
  8. 8.
    Smith PG: Retrospective assessment of the effectiveness of BCG vaccination against tuberculosis using the case-control method. Tubercle 1982; 63:23–35.PubMedCrossRefGoogle Scholar
  9. 9.
    Comstock GW: Vaccine evaluation by case-control or prospective studies. Am J Epidemiol 1990;131:205–207.PubMedGoogle Scholar
  10. 10.
    Raj Narain, Vallishayee RS: BCG vaccination of tuberculous patients and of strong reactors to tuberculin. Bull Int Union Tuberc 1976;51:243–246.PubMedGoogle Scholar
  11. 11.
    Rouillon A, Waaler H: BCG vaccination and epidemiological situation. A decision making approach to the use of BCG. Adv Tuberc Res 1976;19:64–126.PubMedGoogle Scholar
  12. 12.
    Springett VH: The value of BCG vaccination. Tubercle 1965;46:76–84.PubMedCrossRefGoogle Scholar
  13. 13.
    Centers for Disease Control, Tuberculosis Control Division: Tuberculosis among Indochinese refugees—United States, 1979. MMWR 1980;29:383–390.Google Scholar
  14. 14.
    Centers for Disease Control: Use of BCG vaccines in the control of tuberculosis: A joint statement by the ACIP and the Advisory Committee for Elimination of Tuberculosis. MMWR 1988;37:663–675.Google Scholar
  15. 15.
    Ferebee SH: Controlled chemoprophylaxis trials in tuberculosis. A general review. Adv Tuberc Res 1970;17:28–106.Google Scholar
  16. 16.
    Comstock GW, Woolpert SF: Preventive therapy, in Kubica GP, Wayne LG (eds): The Mycobacteria. A Sourcebook. New York, Marcel Dekker, 1984, pp. 1971–1982.Google Scholar
  17. 17.
    Comstock GW, Baum C, Snider DE Jr.: Iso-niazid prophylaxis among Alaskan Eskimos: A final report of the Bethel isoniazid studies. Am Rev Respir Dis 1979;119:827–830.PubMedGoogle Scholar
  18. 18.
    Falk A, Fuchs GF: Prophylaxis with isoniazid in inactive tuberculosis. Chest 1978;73:44–48.PubMedCrossRefGoogle Scholar
  19. 19.
    Comstock GW, Hammes LM, Pio A: Isoniazid prophylaxis in Alaskan boarding schools. A comparison of two doses. Am Rev Respir Dis 1969;100:773–779.PubMedGoogle Scholar
  20. 20.
    Horwitz O, Magnus K: Epidemiologic evaluation of chemoprophylaxis against tuberculosis. Twelve year follow-up of a community-wide controlled trial with special reference to the sampling methods. Am J Epidemiol 1974; 99:333–342.PubMedGoogle Scholar
  21. 21.
    Comstock GW, Ferebee SH: How much isoniazid is needed for prophylaxis? Am Rev Respir Dis 1970;101:780–782.PubMedGoogle Scholar
  22. 22.
    Kopanoff DE, Snider DE Jr, Caras GJ: Isoniazid-related hepatitis. A U.S. Public Health Service cooperative surveillance study. Am Rev Respir Dis 1978;117:991–1001.PubMedGoogle Scholar
  23. 23.
    Rose DN, Schnechter CB, Silver AL: The age threshold for isoniazid chemoprophylaxis: a decision analysis for low-risk tuberculin reactors. JAMA 1986;256:2709–2713.PubMedCrossRefGoogle Scholar
  24. 24.
    American Thoracic Society: Treatment of tuberculosis and tuberculosis infection in adults and children. Am Rev Respir Dis 1986;134:355–363.Google Scholar
  25. 25.
    Dash LA, Comstock GW, Flynn JPG: Isoniazid preventive therapy: Retrospect and prospect. Am Rev Respir Dis 1980;121:1039–1044.PubMedGoogle Scholar
  26. 26.
    Iseman MD: Containment of tuberculosis: Preventive therapy with isoniazid and contact investigation. Chest 1979;76(suppl):801–804.PubMedGoogle Scholar
  27. 27.
    Stead WW: Control of tuberculosis in institutions. Chest 1979;76(suppl):797–800.PubMedGoogle Scholar
  28. 28.
    Centers for Disease Control: The use of preventive therapy for tuberculous infection in the United States. MMWR 1990;39:(No. RR-8)9–12.Google Scholar
  29. 29.
    American Thoracic Society: Diagnostic standards and classification of tuberculosis. Am Rev Respir Dis 1990;142:725–735.CrossRefGoogle Scholar
  30. 30.
    Villarino ME, Dooley SW Jr, Geiter LJ, Castro KG, Snider DE Jr: Management of persons exposed to multidrug-resistant tuberculosis. MMWR 1992;41:No.RR-11, 59–71.Google Scholar

Copyright information

© Springer-Verlag New York, Inc. 1994

Authors and Affiliations

  • George W. Comstock
  • Lawrence J. Geiter

There are no affiliations available

Personalised recommendations